Table 2 Patient demographics and disease characteristics
Age (years) | ||||
|---|---|---|---|---|
Median (range) | 49 (15–82) | |||
Gender | N | % | ||
Men | 74 | 69.2 | ||
Women | 33 | 30.8 | ||
Performance status | ||||
0 | 38 | 35.5 | ||
1-2 | 69 | 64.5 | ||
T classification | ||||
T1 | 23 | 21.5 | ||
T2 | 40 | 37.4 | ||
T3 | 16 | 14.9 | ||
T4 | 28 | 26.2 | ||
T1+T2 | 63 | 58.9 | ||
T3+T4 | 44 | 41.1 | ||
N classification | ||||
N0 | 15 | 14.0 | ||
N1 | 27 | 25.2 | ||
N2 | 44 | 41.1 | ||
N3a | 4 | 3.7 | ||
N3b | 17 | 15.9 | ||
N0+N1 | 42 | 39.3 | ||
N2+N3 | 65 | 60.7 | ||
Clinical stage | ||||
II-III | 64 | 59.8 | ||
IV | 43 | 40.2 | ||
WHO classification | ||||
Type I | 10 | 9.3 | ||
Type II | 21 | 19.6 | ||
Type III | 76 | 71.0 | ||
History of smoking | ||||
No | 71 | 66.4 | ||
Yes | 36 | 33.6 | ||
Alcohol abuse | ||||
No | 100 | 93.5 | ||
Yes | 7 | 6.5 | ||
Hemoglobin level | ||||
≥12 | 10 | 9.3 | ||
<12 | 94 | 87.9 | ||
Unknown | 3 | 2.8 | ||
Best Response | Group A | Group B | ||
CR | 42 | 58 | 38 | 55 |
PR | 18 | 25 | 21 | 30 |
ORR | 60 | 83 | 59 | 85 |
SD | 3 | 4 | 2 | 3 |
PD | 2 | 3 | 5 | 7 |
NE | 7 | 10 | 3 | 4 |